Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. H. Lim
Editorial: First Among Equals-Not for Either Infliximab or Adalimumab in Crohn's Disease-Yet
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Faecal Microbiota Transplantation for Ulcerative Colitis-Not Quite There Yet?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
New England Journal of Medicine
Medicine
Infliximab and Adalimumab Drug Levels in Crohn's Disease: Contrasting Associations With Disease Activity and Influencing Factors
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Efficacy of Adalimumab in Patients With Crohn's Disease and Failure to Infliximab Therapy: A Clinical Series
Revista Espanola de Enfermedades Digestivas
Medicine
Gastroenterology
Clinical Efficacy of Adalimumab Versus Infliximab and the Factors Associated With Recurrence or Aggravation During Treatment of Anal Fistulas in Crohn's Disease
Intestinal Research
Gastroenterology
Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease
The Lancet
Medicine
Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Long-Term Safety of Adalimumab in Clinical Trials in Adult Patients With Crohn's Disease or Ulcerative Colitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Löfgren Syndrome Developing During Infliximab Therapy for Crohn's Disease: A Case Report
Canadian Journal of General Internal Medicine
